Twist Bioscience CEO Emily M. Leproust disposes of USD 910,033 in common shares

TWST•2026-10-07

Twist Bioscience CEO Emily M. Leproust sold 4,548 common shares on Oct. 5, 2026, for USD 910,033.

1. Share sale

Leproust sold 4,548 common shares on Oct. 5, 2026, at weighted-average prices ranging from $200.4379 to $207.4556 per share. She directly held 562,760 shares after the transactions.

Sources

Twist Bioscience CEO Emily M. Leproust disposes of USD 910,033 in common shares

Sec

Twist Bioscience CEO Emily M. Leproust disposes of USD 910,033 in common shares

1. Share sale

Related News

Ibotta schedules Q3 2026 results conference call

Camden Property Trust schedules third-quarter 2026 earnings release and conference call

The day ahead—North America, October 8

Sources

Twist Bioscience CEO Emily M. Leproust disposes of USD 910,033 in common shares

UMB Financial schedules conference call on third-quarter 2026 results

SEALSQ VP R&DSS Jean-Pierre Enguent disposes of 35,000 shares for $85,935.50